BIVRX vs. UPRO
Compare and contrast key facts about Invenomic Fund (BIVRX) and ProShares UltraPro S&P 500 (UPRO).
BIVRX is managed by Invenomic. It was launched on Jun 18, 2017. UPRO is a passively managed fund by ProShares that tracks the performance of the S&P 500 Index (300%). It was launched on Jun 23, 2009.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BIVRX or UPRO.
Correlation
The correlation between BIVRX and UPRO is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BIVRX vs. UPRO - Performance Comparison
Key characteristics
BIVRX:
-0.87
UPRO:
1.79
BIVRX:
-1.20
UPRO:
2.22
BIVRX:
0.87
UPRO:
1.30
BIVRX:
-0.32
UPRO:
2.21
BIVRX:
-1.09
UPRO:
10.56
BIVRX:
9.92%
UPRO:
6.37%
BIVRX:
12.47%
UPRO:
37.64%
BIVRX:
-34.31%
UPRO:
-76.82%
BIVRX:
-30.90%
UPRO:
-9.44%
Returns By Period
In the year-to-date period, BIVRX achieves a -1.00% return, which is significantly lower than UPRO's 1.35% return.
BIVRX
-1.00%
-0.40%
4.31%
-10.03%
9.71%
N/A
UPRO
1.35%
-7.94%
7.63%
68.05%
20.66%
24.17%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BIVRX vs. UPRO - Expense Ratio Comparison
BIVRX has a 2.48% expense ratio, which is higher than UPRO's 0.92% expense ratio.
Risk-Adjusted Performance
BIVRX vs. UPRO — Risk-Adjusted Performance Rank
BIVRX
UPRO
BIVRX vs. UPRO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Invenomic Fund (BIVRX) and ProShares UltraPro S&P 500 (UPRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BIVRX vs. UPRO - Dividend Comparison
BIVRX's dividend yield for the trailing twelve months is around 3.59%, more than UPRO's 0.91% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | 3.59% | 3.55% | 2.62% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
UPRO ProShares UltraPro S&P 500 | 0.91% | 0.93% | 0.74% | 0.52% | 0.06% | 0.11% | 0.41% | 0.63% | 0.00% | 0.12% | 0.34% | 0.22% |
Drawdowns
BIVRX vs. UPRO - Drawdown Comparison
The maximum BIVRX drawdown since its inception was -34.31%, smaller than the maximum UPRO drawdown of -76.82%. Use the drawdown chart below to compare losses from any high point for BIVRX and UPRO. For additional features, visit the drawdowns tool.
Volatility
BIVRX vs. UPRO - Volatility Comparison
The current volatility for Invenomic Fund (BIVRX) is 4.01%, while ProShares UltraPro S&P 500 (UPRO) has a volatility of 13.48%. This indicates that BIVRX experiences smaller price fluctuations and is considered to be less risky than UPRO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.